Sign in
4

Changes in Ownership

Tempest Therapeutics, Inc. Filed Acc 0001193125-26-274545

Options or other derivatives

  • Director acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Yee John D. Director 2026-06-04 Grant or award · Stock Option (right to buy) +25,000 25,000 D
Loading xslF345X06/ownership.xml…